DOJ, SEC Investigating GlaxoSmithKline for Possible FCPA Violations
By Mary Jacoby | August 13, 2010 12:21 pm

The Justice Department and Securities and Exchange Commission are investigating the pharmaceutical giant, GlaxoSmithKline, for possible violations of the Foreign Corrupt Practices Act, the Financial Times reported.

It has been known for months that the DOJ’s Criminal Fraud Section and the SEC are investigating several pharmaceutical companies for potential FCPA violations. But it has not been publicly known that Glaxo Smith Kline was one of companies under scrutiny.

In April, the DOJ and SEC sent letters to at least five other major pharmaceutical companies: AstraZeneca PLC; Baxter International Inc.; Eli Lilly & Co.; Bristol-Myers Squibb Co.; and Merck & Co

The letters, which were later described to Main Justice, said the agencies were focusing on the companies’ business in several countries, which varied by firm but included Brazil, China, Germany, Greece, Italy, Poland, Russia and Saudi Arabia.

GlaxoSmithKline told FT that it had received “inquiries” from US authorities, but that it disclosed the issue only “reactively,” telling only a few reporters in April. However, the inquiry into the company was not disclosed in news reports at the time.

An industry attorney familiar with the probe told FT the Justice Department was looking at whether the companies had ignored a “systematic risk” inherent in the global drugs business, though it is not clear precisely what activity is under investigation.

Facebook Twitter Linkedin Email


  1. Anderson says:

    …Check this out…

    [...]Wow, superb weblog structure! How lengthy have you ever been running a blog for?[...]…

  2. NBA Picks says:

    [...]the time to read or visit the content or sites we have linked to below the[...]……

    [...]here are some links to sites that we link to because we think they are worth visiting[...]……

  3. modele photo says:


    [...]The total glance of your site is great, let smartly as the content![...]…

  4. bike games says:

    Websites we think you should visit…

    [...]although websites we backlink to below are considerably not related to ours, we feel they are actually worth a go through, so have a look[...]……

  5. tatuaggi says:

    Blogs ou should be reading…

    [...]Here is a Great Blog You Might Find Interesting that we Encourage You[...]……

Leave a Comment

You must be logged in to post a comment.

Barnes & Thornburg LLP
ANALYSIS: “Hide No Harm Act Of 2015” Targets Employers, Directors and Officers more
Sheppard, Mullin, Richter & Hampton LLP
ANALYSIS: The Schrems Decision: How the End of Safe Harbor Affects Your FCPA Compliance Plan more
Paul Hastings LLP
ANALYSIS: The Yates Memorandum: Increasing the Perils of Parallel Proceedings more
Arnold & Porter LLP
ANALYSIS: Global Reach? Extraterritorial Application of US Criminal Law  more
Dechert LLP
ANALYSIS: U.S. Chamber of Commerce Joins Chorus Pushing For Overhaul in SEC Enforcement Practices more
Orrick, Herrington & Sutcliffe LLP
ANALYSIS: There’s a New Sheriff In Town: Coverage for World Bank Investigations and Sanctions more
An error has occurred, which probably means the feed is down. Try again later.